Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Innokin Wins "Golden Leaf Award for Innovation" at GTNF 2023 for World’s First Metal-free Conductive Ceramic Coil

    September 21, 2023

    Introducing CleverAutomations: Ready-to-Use Automation Journeys for Recurring Revenue Growth

    September 21, 2023

    HUAWEI eKit Joins Hands with Distribution Partners to Explore Unlimited Opportunities in the SME Market

    September 21, 2023
    • Home
    • Contact Us
    Gulf ExposéGulf Exposé
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Gulf ExposéGulf Exposé
    Home » South Korean Biotech Company Portrai Inc. Adopts Infortrend Storage to Enable AI Data Analysis for Pharmaceutical Drug Development
    PR Newswire

    South Korean Biotech Company Portrai Inc. Adopts Infortrend Storage to Enable AI Data Analysis for Pharmaceutical Drug Development

    September 12, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    TAIPEI, Sept. 12, 2023 /PRNewswire/ —  Infortrend® Technology, Inc. (TWSE: 2495), the industry-leading enterprise storage manufacturer, provided South Korean biotech company Portrai Inc. with EonStor GS enterprise unified storage solution to enable their innovative research technology combining AI and RNA analysis for pharmaceutical drug development.

    Portrai Inc. specializes in a cutting-edge RNA analysis technology called “Spatial Transcriptomics” to study novel targets and disease-related biomarkers. The company uses the unique combination of AI and Spatial Transcriptomics aiming to revolutionize pharmaceutical drug development. This analysis technology continuously generates data ranging from 10GB to 1TB for an image sized 1cm2, which requires storage space. Cloud storage solutions were hindered due to low internet throughput and expensive monthly subscriptions for enterprise-grade plans. Thus, the company was looking for a reasonably priced on-site solution capable of storing and processing massive amounts of research data generated by AI computation.

    Portrai chose Infortrend’s storage for its reputation of system stability and performance. To enable their advanced and demanding RNA analysis technology, the biotech company was advised to deploy Infortrend’s EonStor GS 3024 unified storage and JBOD JB3060L, fully loaded with 84 NL-SAS drives x 18TB. This solution easily tackled the demand for data storage by offering up to 1.2PB of available storage. Moreover, it features a redundant controller design to minimize downtime, data replication/mirroring for backup, future scalability for the ever-growing research data, and efficient management with the browser-based  interface.

    “In the course of pharmaceutical drug development, Spatial Transcriptomics and AI analysis generate massive amounts of data. Infortrend offers storage stability and capacity, combined with reasonable pricing, good customer service, and technical support, so we are extremely satisfied with Infortrend’s storage solution,” said Daeseung Lee, CEO of Portrai Inc.

    Learn more about EonStor GS

    Connect with Infortrend on LinkedIn

    Contact Infortrend to Make an Inquiry

    About Infortrend

    Infortrend (TWSE: 2495) has been developing and manufacturing storage solutions since 1993. With a strong emphasis on in-house design, testing, and manufacturing, Infortrend storage delivers performance and scalability with the latest standards, user friendly data services, personal after-sales support, and unrivaled value. For more information, please visit www.infortrend.com

    Infortrend® and EonStor® are trademarks or registered trademarks of Infortrend Technology, Inc.; other trademarks are the property of their respective owners.

    Cision View original content:https://www.prnewswire.com/ru/press-releases/south-korean-biotech-company-portrai-inc-adopts-infortrend-storage-to-enable-ai-data-analysis-for-pharmaceutical-drug-development-301920900.html

    Related Posts

    Innokin Wins "Golden Leaf Award for Innovation" at GTNF 2023 for World’s First Metal-free Conductive Ceramic Coil

    September 21, 2023

    HUAWEI eKit Joins Hands with Distribution Partners to Explore Unlimited Opportunities in the SME Market

    September 21, 2023

    Uniken Selected as Strategic Mobile and Cybersecurity Partner for Indian Government Initiative

    September 21, 2023

    Xiamen Airlines Chairman Zhao Dong met with Qatar Airways Group CEO Akbar Al Baker

    September 21, 2023

    Huawei’s David Wang: Accelerate Intelligence with Custom-built AI Models for All Industries

    September 21, 2023

    VAPORESSO COSS Triumphs at Golden Leaf Awards, Securing Innovation Award

    September 21, 2023
    Latest News

    From India to Brazil, leadership transition marks G20 Summit’s conclusion

    September 11, 2023

    African Union Inducted into G20 on India’s Initiative

    September 9, 2023

    Biden and Modi cement ties as India ascends global stage

    September 9, 2023

    UN calls for greater female representation in police forces worldwide

    September 8, 2023

    Digital work revolution sees the world’s gig economy expand by 12 percent

    September 8, 2023

    AI drives MENA Newswire’s entry into Saudi digital media

    September 8, 2023

    ASEAN Summit in Jakarta sees PM Modi advocating India’s growing global impact

    September 7, 2023

    Air Canada faces backlash as passengers evicted for refusing vomit-soaked seating

    September 7, 2023
    © 2021 Gulf Exposé | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.